Published in Vox Sang on January 01, 2011
Beyond immunohaematology: the role of the ABO blood group in human diseases. Blood Transfus (2013) 1.18
Cytoadherence in paediatric malaria: ABO blood group, CD36, and ICAM1 expression and severe Plasmodium falciparum infection. Br J Haematol (2012) 0.89
ABO blood group and the risk of placental malaria in sub-Saharan Africa. Malar J (2011) 0.88
Exosome poly-ubiquitin inhibits platelet activation, downregulates CD36 and inhibits pro-atherothombotic cellular functions. J Thromb Haemost (2014) 0.78
Malaria Parasitaemia among Blood Donors in Ilorin, Nigeria. Afr J Infect Dis (2015) 0.76
Influence of host factors and parasite biomass on the severity of imported Plasmodium falciparum malaria. PLoS One (2017) 0.75
Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22
DNA commission of the International Society of Forensic Genetics: Recommendations on the interpretation of mixtures. Forensic Sci Int (2006) 3.20
Current status of solvent/detergent-treated frozen plasma. Transfusion (1998) 2.24
DNA Commission of the International Society of Forensic Genetics (ISFG): an update of the recommendations on the use of Y-STRs in forensic analysis. Forensic Sci Int (2006) 2.22
DNA Commission of the International Society of Forensic Genetics (ISFG): an update of the recommendations on the use of Y-STRs in forensic analysis. Int J Legal Med (2006) 2.00
Nomenclature for factors of the HLA system, 1990. Tissue Antigens (1991) 1.98
Nomenclature for factors of the HLA system, 2002. Tissue Antigens (2002) 1.89
Nomenclature for factors of the HLA system, 1991. WHO Nomenclature Committee for factors of the HLA system. Tissue Antigens (1992) 1.58
Nomenclature for factors of the HLA system, 2004. Tissue Antigens (2005) 1.57
Albumin supplementation in the critically ill. A prospective, randomized trial. Arch Surg (1990) 1.47
Paternity Testing Commission of the International Society of Forensic Genetics. Recommendations on genetic investigations in paternity cases. Int J Legal Med (2003) 1.46
Rheumatoid arthritis and B lymphocyte alloantigen HLA-DRw4. J Rheumatol (1980) 1.41
Nomenclature for factors of the HLA system, 1998. Tissue Antigens (1999) 1.40
[The HL-A-system in paternity testing (author's transl)]. Z Rechtsmed (1974) 1.39
Universal leucocyte-depletion of blood components: cell concentrates and plasma. Vox Sang (2001) 1.39
Large-volume hemocytometer chamber for accurate counting of white cells (WBCs) in WBC-reduced platelets: validation and application for quality control of WBC-reduced platelets prepared by apheresis and filtration. Transfusion (1993) 1.39
Defective macrophage function in a patient with common variable immunodeficiency. N Engl J Med (1982) 1.38
Nomenclature for factors of the HLA system, 1995. Tissue Antigens (1995) 1.34
HLA antigens in inflammatory bowel disease. Gastroenterology (1982) 1.31
The relation of parental sex and age to recombination in the HL-A system. Hum Hered (1973) 1.30
DNA commission of the International Society of Forensic Genetics: recommendations on forensic analysis using Y-chromosome STRs. Int J Legal Med (2001) 1.28
Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors. Bone Marrow Transplant (2005) 1.28
DNA Commission of the International Society for Forensic Genetics (ISFG): recommendations regarding the role of forensic genetics for disaster victim identification (DVI). Forensic Sci Int Genet (2006) 1.28
Current status of immunoprophylaxis with anti-D immunoglobin. Vox Sang (2003) 1.22
Nomenclature for factors of the HLA system, 2000. Tissue Antigens (2001) 1.21
HLA-DR and Hashimoto's thyroiditis. Tissue Antigens (1980) 1.20
Nomenclature for factors of the HLA system, 1994. Tissue Antigens (1994) 1.19
Nomenclature for factors of the HLA system, 1996. Tissue Antigens (1997) 1.18
Nomenclature for factors of the HLA system, 1995. Hum Immunol (1995) 1.16
Genotyping of the human platelet antigen systems 1 through 5 by multiplex polymerase chain reaction and ligation-based typing. Transfusion (1996) 1.13
DNA commission of the International Society of Forensic Genetics: Recommendations on the evaluation of STR typing results that may include drop-out and/or drop-in using probabilistic methods. Forensic Sci Int Genet (2012) 1.11
Immunoglobulin allotype markers and HLA DR genes in type I diabetes mellitus. Metabolism (1984) 1.10
Strategy to detect chimerism in allogeneic bone marrow transplant recipients by PCR-amplification fragment length polymorphism analysis of microsatellite polymorphisms. Vox Sang (1995) 1.10
Nomenclature for factors of the HLA system, 1989. Tissue Antigens (1990) 1.10
Nomenclature for factors of the HLA system, 2000. Eur J Immunogenet (2001) 1.08
Humoral immunodeficiency to bacterial antigens in patients with juvenile onset diabetes mellitus. Diabetologia (1976) 1.08
ISFG: recommendations regarding the use of non-human (animal) DNA in forensic genetic investigations. Forensic Sci Int Genet (2010) 1.06
Fy phenotype and gender determine plasma levels of monocyte chemotactic protein. Transfusion (2001) 1.05
DNA Commission of the International Society of Forensic Genetics: recommendations on forensic analysis using Y-chromosome STRs. Forensic Sci Int (2001) 1.04
HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis. J Rheumatol (1984) 1.02
Nomenclature for factors of the HLA system, 1990. Hum Immunol (1991) 1.01
Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease. Acta Endocrinol (Copenh) (1989) 1.00
Localization of MPI, PKM2, IDHM, and the alpha subunit of hexosaminidase (HEXA) to the q21 leads to qter region of human chromosome 15. Cytogenet Cell Genet (1978) 0.99
High-throughput multiplex PCR genotyping for 35 red blood cell antigens in blood donors. Vox Sang (2011) 0.99
Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha. Clin Exp Immunol (1992) 0.98
Current status of solvent/detergent-treated frozen plasma, whole-blood inline filtration, and Creutzfeldt-Jakob disease. Transfusion (1999) 0.97
An update to HLA nomenclature, 2010. Bone Marrow Transplant (2010) 0.96
DNA recommendations 1997 of the International Society for Forensic Genetics. Vox Sang (1998) 0.95
Lymphocyte transformation to denatured type I collagen and B lymphocyte alloantigens in rheumatoid arthritis. Arthritis Rheum (1980) 0.94
Nomenclature for factors of the HLA system, 1991. Hum Immunol (1992) 0.93
Radiation-induced red cell damage: role of reactive oxygen species. Transfusion (1997) 0.92
Current performance of patient sample collection in the UK. Transfus Med (2004) 0.92
HLA-DRw3 and systemic lupus erythematosus. Arthritis Rheum (1980) 0.92
Ia-Type alloantigens and humoral autoimmune responsiveness in insulin-dependent diabetes mellitus. Metabolism (1979) 0.92
Influence of clinical factors on the haemolysis marker haptoglobin. Eur J Clin Invest (2006) 0.91
HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter. J Clin Endocrinol Metab (1983) 0.91
Nomenclature for factors of the HLA System, 1998. Hum Immunol (1999) 0.91
Genotyping for red blood cell polymorphisms. Vox Sang (2009) 0.90
Evaluation of four monoclonal antibodies against HLA-B27 for their reliability in HLA-B27 typing with flow cytometry (FC): comparison with the classic microlymphocytotoxic test (MLCT). Cytometry (1996) 0.89
A comparative analysis of different methods for routine blood component preparation. Transfus Med Rev (1997) 0.89
Use of intraoperative blood salvage during orthotopic liver transplantation. Arch Surg (1985) 0.89
HLA-antigen distribution in seminoma, HCG-positive seminoma and non-seminomatous tumours of the testis. Urol Res (1989) 0.88
Terminal deletion of (1)(q42) and its phenotypical manifestations. Hum Genet (1978) 0.88
Nomenclature for factors of the HLA system, 2000. Hum Immunol (2001) 0.88
Alpha-1-antitrypsin phenotypes in acute anterior uveitis. Ophthalmic Res (1982) 0.88
Detection of bacterial contamination of platelet concentrates. Vox Sang (2007) 0.88
Human plasma and tirilazad mesylate protect stored human erythrocytes against the oxidative damage of gamma-irradiation. Transfus Med (2000) 0.88
The importance of HLA genes to susceptibility in the development of juvenile diabetes mellitus. A study of 93 patients and 68 first degree blood relations. Diabete Metab (1977) 0.87
Genetic and population structure of four Sardinian villages. Ann Hum Genet (1985) 0.87
Granulocytes in gradient separations of stored blood. Transfusion (1984) 0.87
Biobanks of blood from donors and recipients of blood products. Vox Sang (2008) 0.86
Occult hepatitis B infection in blood donors. Vox Sang (2008) 0.86
Nomenclature for factors of the HLA System, 1996. Hum Immunol (1997) 0.86
[Islet-cell antibodies in juvenile diabetes mellitus (author's transl)]. Dtsch Med Wochenschr (1977) 0.86
Haemolytic transfusion reactions due to HLA antibodies. A prospective study combining red-cell serology with investigations of chromium-51-labelled red-cell kinetics. Lancet (1987) 0.86
Corneal grafting--strategy for optimal results. Tissue Antigens (1989) 0.85
Nomenclature for factors of the HLA system, 1996. Eur J Immunogenet (1997) 0.85
Immunoglobulin G-insulin antibodies and immune region-associated alloantigens in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1979) 0.85
Molecular genetics of the HLA complex. Wien Klin Wochenschr (2001) 0.85
Concanavalin A-induced suppressor cell activity and in vitro immunoglobulin secretion in rheumatoid arthritis: correlation with clinical and immunological parameters. Rheumatol Int (1981) 0.85
HLA-DR antigens and disease patterns of rheumatoid arthritis. Rheumatol Int (1983) 0.84
Nomenclature for factors of the HLA system, 1989. Hum Immunol (1990) 0.84
Letter: Is HLA-B7 a marker associated with a protective gene in juvenile-onset diabetes mellitus? N Engl J Med (1976) 0.84
Transfer of congenital factor XI deficiency from a donor to a recipient by liver transplantation. N Engl J Med (1987) 0.84
Nomenclature for factors of the HLA system, 1994. Hum Immunol (1994) 0.84
B-lymphocyte alloantigens and insulin-dependent diabetes mellitus. Lancet (1977) 0.83
Specificities of anti-platelet antibodies in multitransfused patients with haemato-oncological disorders. Br J Haematol (1996) 0.83
HLA-A, B, C gene and haplotype frequencies in Vienna. An analysis of family data. Hum Genet (1977) 0.83
Algorithm for the computation of plausibilities of paternity in the HLA system. Z Immunitatsforsch Immunobiol (1976) 0.83
Target platelet antigens of autoantibodies in patients with primary biliary cirrhosis. Hepatology (1997) 0.83
Lymphocyte subpopulations altered during blood storage. N Engl J Med (1983) 0.83
Genetic analysis and biological properties of products of the third SD (AJ) locus of the HL-A region. Transplant Proc (1973) 0.83
[Analysis of the linkage between the HL-A loci and the genes of other markers (author's transl)]. Humangenetik (1974) 0.82
HLA B13, B17, B37 and Cw6 in psoriasis vulgaris: association with the age of onset. Arch Dermatol Res (1978) 0.82
Letter: Genetic factors on insulin antibodies in juvenile-onset diabetes. N Engl J Med (1976) 0.82
Nomenclature for factors of the HLA system, 1991. Immunobiology (1993) 0.82
HLA-B8 in caucasian patients with systemic lupus erythematosus. Scand J Rheumatol (1978) 0.82
Human platelet antigen gene frequencies in the Austrian population. Haemostasis (1995) 0.82
What are a patient's current chances of finding a matched unrelated donor? Twenty years' central search experience in a small country. Bone Marrow Transplant (2011) 0.81
Risk of hepatitis C virus (HCV) transmission by anti-HCV-negative blood components in Austria and Germany. Ann Hematol (1996) 0.81